RxAnte
Portland, US · Delaware corporation · 1 known investors
RxAnte provides tech-enabled, value-based pharmacy care management, including analytics and quality-improvement tools plus high-touch pharmacy services, for health plans, providers, and pharmacies. Its programs aim to improve medication use and health outcomes for at-risk members while lowering healthcare costs.
Founders & leadership
JB
Joshua BennerCo-founder
JB
Josh BennerCo-Founder & CEO
JS
Joshua S. BennerFounder & Chief Executive Officer
LJ
Lisa JurinkaSVP, General Counsel
NC
Niteesh ChoudhrySVP, Chief Medical and Science Officer
AJ
Amie JoyceSVP, Head of Technology Operations
PB
Patrick BakerSVP, General Manager at Mosaic Pharmacy Service
JF
Jessica FrankSVP, Client Success
MK
Mohit KaushalNamed on SEC filing
NS
Nicholas ShapiroNamed on SEC filing
GL
Greg LahensNamed on SEC filing
MW
Marc WisePresident
Investors · 1
Reported raises · per SEC filings
Form D private placements$10.9M disclosed across 1 round · 2020
▶$10.9MraisedMay 2022 · 7 investors · Other Health CareRule 506(b)
▶$10.9MraisedMay 2022 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mohit KaushalDirector
- Nicholas ShapiroDirector
- Greg LahensExecutive Officer
- Marc WiseExecutive Officer
- Brenton BurnsDirector
- Joshua BennerExecutive Officer, Director
- Corbin DirectorExecutive Officer
- Eileen CasalExecutive Officer
- Jonathan PhillipsDirector
- Loren LidskyExecutive Officer
- Chronis ManolisDirector
- Offering amount
- $10.9M
- Amount sold
- $10.9M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapRxVantage38 shared keywordsPlatform connecting healthcare providers with life science experts to access critical information and insights.
Redsail Technologies29 shared keywordsRedSail Technologies develops pharmacy management software and clinical programs for community, long-term care, outpatient, and pharma customers. Its integrated tools aim to improve patient engagement, medication adherence, and health outcomes in the pharmacy industry.
Guardant Health20 shared keywordsGuardant Health develops blood-based testing (liquid biopsy) for cancer detection and monitoring across all stages of the disease. The company serves oncologists, patients, and biopharmaceutical firms with FDA-approved tests for cancer screening, early-stage risk assessment, and treatment selection.
Companies competing with RxAnte for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does RxAnte do?
- RxAnte provides tech-enabled, value-based pharmacy care management, including analytics and quality-improvement tools plus high-touch pharmacy services, for health plans, providers, and pharmacies. Its programs aim to improve medication use and health outcomes for at-risk members while lowering healthcare costs.
- Who founded RxAnte?
- RxAnte was founded by Joshua Benner, Josh Benner, Joshua S. Benner.
- Who are RxAnte's investors?
- RxAnte's investors include Primus Capital.
- How much funding has RxAnte raised?
- RxAnte has disclosed $10.9M raised across 1 round.
- Where is RxAnte headquartered?
- RxAnte is headquartered in Portland, US.